Reddit Posts
$VNDA reported positive numbers yesterday
$LLY vs $NVO: Medicare GLP Bridge program is a boon to Lilly. Novo? Not so much...
Novo Nordisk (NVO) and Madrigal (MDGL) both have something at stake in a new low-dose semaglutide combo
θθδΈιθ½ε¦δ»£θ‘¨MASHζ²»ηζεοΌ
Does lower liver fat mean MASH treatment is working? What are the implications for investors?
Will Chinaβs GLP-1 market get hit with the same price cuts as insulin?
Inventiva pharma last news -MASH
Healthcare is the sector I ignored the longest - feel like was a mistake
Citi predicts 410% rally for BMEA (currently under $1.50)
Citi says BMEA will Rally to $7 (it's less than $1.5 now) β Big catalyst ahead
Citi says BMEA will Rally to $7 (it's less than $1.5 now) β Tomorrow could get interesting
Citi says BMEA will Rally to $7 (it's less than $1.5 now) β Tomorrow could get interesting
Citi says BMEA will Rally to $7 (it's less than $1.5 now) β Tomorrow could get interesting
Citi says BMEA will Rally to $7 (it's less than $1.5 now) β Tomorrow could get interesting
Citi says BMEA will Rally to $7 (it's less than $1.5 now) β Tomorrow could get interesting
Citi says BMEA will Rally to $7 (it's less than $1.5 now) β Tomorrow could get interesting with a big catalyst coming
CUVL (Clinuvel) - profitable peptide biotech, $226m EV, Phase 3 readout in less than 100 days. Cashed up, no debt.
$MODD Due Diligence β A brand new FDA-Cleared Insulin delivery system
DNUT: edging closer to value with FCF and EBITDA multiples expected to decline materially. + hype potential through PokΓ©mon
Buy DNUT on weakness today after blowout quarter
The First Milestone of Monetizing Pharmaceutical Research
CRBP: I think this is one of the most overlooked biotech catalysts of 2026
Are m***coins actually a better market than stocks?
Nobody who lost money on NVO can say they werenβt warned
Several S&P 500 companies just beat earnings and got punished for it anyway. A look at why
NVO's Wegovy pill is estimated to own 89% of US GLP pill market share
Fractyl Health (GUTS) Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation
β EMBC- The mistake of the Retail Investor is to rely entirely on AI. Setting her the wrong algorithms, thereby missing the most important moments. Which is not available for AI.βΌοΈ
Buy China? China has been able to produce AI models like DeepSeek and GLP 5.2. It has memory stocks like CXMT and YMTC and big tech like BABA, Tencent, PDD, etc. All trading at a PE less than <15 and PEG ratio<1.5
SYK and general stock research and how im starting to use AI to research
The weight loss race: Eli Lilly vs. Novo Nordisk
The Great Rotation: money is fleeing AI bagholders and waddling straight into fat-loss drugs
$LEXX at $0.54 is the Highest-Stakes Game of Chicken in the GLP-1 Space Right Now π
Trying to understand the opportunity with $CNXU
LFVN is back baby! Spiking in the last minutes.
I am all for stock investing, speculation, and saving American business... However Wendy's is a victim to GLP-1 and weight loss peptides:
Wendy's (WEN) - Regards you've been promoted from Employee to Shareholder
Achieve Life Sciences [ACHV]: Upcoming Nicotine Cessation Drug
Achieve Life Sciences [ACHV]: Upcoming Nicotine Cessation Drug
DD: Why Beaten-Down Booze Stocks Could Be the Next Oil-Style Recovery Trade
$LEXX: Why the Most Explosive Chapter in this Company's History is Quietly Baking in the Lab Right Now π§ͺπ
Eli Lilly is ready to soar with their latest results get ready for Triple Action GLP's
Retatrutide is probably gonna cure your worst trading habits
Money printer goes $BRBR
The Great Protein Shortage of 2026 - DD
The Great Protein Shortage of 2026 coming - DD
$HIMS - The former Netflix CFO just bought $1.2M of stock.
π©EMBC - Any positive news, even the most insignificant, will serve as a catalyst for explosive growth in stocks.
π©EMBC- Action movement. Waiting for the catalyst.β
Tandem Diabetes ($TNDM) 10x play or getting bought out privately in the next few years ($825k bet)
Why the Market is Completely Mispricing $LEXX Right Now π π¨
WVE: Wall street dosen't know how how to price clinical trial data
WVE: Wall street dosen't know how how to price clinical trial data
Wave Life Sciences (WVE): Wall Street can't price in Clinical trial data
π©π©EMBC - TEVA , Zydus,Sandoz in π¨π¦
β Analysis of the BofA Healthcare Conference: How Embecta (EMBC) is Changing the Rules in the GLP-1 Market
Breaking Down the CNXU Platform, the Market Targets, and What the Regulatory Timeline Actually Means
CNXU β Breaking Down the Platform, the Market Targets, and What the Regulatory Timeline Actually Means
Fractyl Health (GUTS) valuations
85% recurring revenue. 5x revenue growth in 5 years. The biotech royalty engine Wall Street forgot.
Best Penny Stocks To Watch...here are ones we are watching
Wall Street thought Ozempic would kill the gym industry. Planet Fitness just signed a deal with the company that prescribes it.
What could be Moderna's "ozempic moment"? (Why MRNA is a great bet right now)
Hims & Hers (HIMS) What Moves Hims From Here?
ResMed beat earnings and dropped 6%. Ran the fundamentals and I think the market is missing something here.
I am extremely pessimistic regarding the intermediate future. Are these investments resilient enough to handle what Iβm afraid will happen?
$LEXX: Why a $15M Market Cap for a Proven GLP-1 Platform is a Statistical Absurdity ππ
π© EMBC-Discrepancies with reality. Stock price anomaly.
When your calls are under water, grab a fatty, they float eventually. PLNT DD.
If you still have a STRONG bull conviction on a earnings sell off, heres what to do:
π©Accelerated Repricing Phase . A company with 100 years of history.
Stock to watch : FDA reports liver failure in patient taking Eli Lillyβs Foundayo (GLP-1 pill)
Trump says GLP-1 weight-loss drugs coming at $50 for Medicare patients
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
LFVN - Either it will squeeze or my nuts will
Is Lexaria ($LEXX) the next Billion Dollar Buyout? π π¨
LLY: The Foundayo bull case requires assuming people don't have sex
LLY: The Foundayo bull case requires assuming people don't have sex
LLY: The Foundayo bull case requires assuming people don't have sex
π¨ LLY: The Foundayo bull case requires assuming people don't fuck π¨
π¨ LLY: The Foundayo bull case requires assuming people don't fuck π¨
Hims & Hers +7% premarket after expanding access to full range of FDA-approved GLP-1 weight loss drugs
Hims & Hers +7% premarket after expanding access to full range of FDA-approved GLP-1 weight loss drugs
Mentions
Actually, this was true. I hate that you were downvoted! (Also I drink them a lot and they really helped me lose weight, so I hated reading about it!) From what I understand, they have taken steps to prevent it from ever happening again, but this was a thing back around 2022 ish when I started on a GLP-1, and there was a shortage because of it.
Fewer than 90% of companies might need it, but a solid chunk will still want the technology - especially for drug discovery, materials science, space tech, quantum computing etc. Just look at Eli Lilly - its stock surged as the company capitalized on big demand for its GLP-1 weight loss drugs while leveraging AI to accelerate research, development, and production.
Diet drinks do exist. GLP-1s are killing PEP a lot harder than KO since Coke is a beverage pure play
LLY.. i figured the GLP craze would lead to a lot of upside. also VLO and LNG.. although they're very volatile..
Forget that; GLP-1s are killing junk food.
Iirc the only reason obesity rates are beginning to decline are the GLP-1 drugs like ozempic, most people still eat a ton of processed food and drink a ton of soda/sparking waters Definitely not healthy
Took too much GLP1. Never feel like eating. Had like 500 calories today :/
i went heavy with leaps in Aug 2025, when the ATTAIN-1 results came out and disappointed the market... the combination of growth, margin, and non-"AI bubble" exposure makes this my main investment... with a future pipeline of reta, elora, brenip, and eloratzp, $LLY is in the lead and it's not even close... and that's not even mentioning the non-disclosed preclinical assets like the oral small molecule GIP agonists, oral small molecule GCG agonists, oral small molecule amylin agonists, the long acting GLP injections, and the multitude of cardiometabolic siRNAs and ASOs... and that's only obesity... they are actively taking their GLP profits and investing in neuroscience, oncology, and immunology...
Looks like thereβs a new Will Ferrell movie dropping. I guess heβs on the GLP1s now.
He looks like if someone gave Andy Warhol and MBA and too much GLP-1
The weight loss is great for some people but I feel like the other shoe is going to drop on these at some point so be mindful of that. There are going to be longer term side effects that pop up, maybe the result of bone density going down, etc... Possibly even addiction. I see some of these people on TV and you know they are on GLP-1s and they just look hollowed out and skeletal which can not be healthy for their system.
2000mg of metformin per day (maximum dosage) is a cheat code for losing weight. It's obviously not like a GLP-1 PER SE, and it takes several months for the appetite-suppressing effects to build up, but it's great. It induces early satiety, reduces hunger hormones in general, and slows gastric emptying keeping you full for longer. It's dirt freaking cheap compared to a GLP-1. I've lost 65 pounds since I've been put on it. Doctors tend to put people on 500 - 1000 mg a day, but that's not enough; you need the full 2000mg a day dose for peak effect. Not sure if it's less useful if you have diabetes, like GLP-1s are less effective for weight loss if you have diabetes, but I didn't have diabetes when my nutritionist doctor put me on it for weight loss so it might be more effective.
Lilly's report today backs you up, revenue was up 39%. Growth isn't my issue with LLY, it looks expensive to me next to its FCF. Priced like that, holders end up white-knuckling every bad GLP headline.
Not nowadays, the rich have had lower levels of obesity even before GLP1s.
Medical devices is something I tend to try to stay away from since itβs just out my circle of competence. Wonder how much GLP1s are improve long term health and impacting a ton of companies.
Did you get in? Up a bit this morning. Q3 data looks good. Hoping bottom is in now. If WVE007 posts big numbers in high BMI people or works well post GLP-1 treatment for maintenance, well over 10x.
solve the inflation problem by making everyone eat less, by injecting GLP-1
Yeah, I am not an expert by any means on drug development but it is really crazy. The only non expert thesis I hold is that GLP-1s will solve the drug epidemic in America in under a decade. So, I am playing around with a long/short strategy of betting against rehab and detox centers.
Don't the GLP meds kindda contradict that? Not a direct cure but definitely massive helpers for prevention
Calls on the GLP that will remove you from social media addiction.
Those are all collaborative efforts, none purely American-led innovation, no? LLM was a Google research lab which is multinational. Starlink isβ¦ just a satcom system solved with the power of raw capitalism, and GLP-1βs recent breakthrough; yeah Iβll give you that. Thatβs a good one.
Nothing since besides LLMs, landing rockets, starlink and GLP-1s.
Most Americans are now plugging GLP1's, which make it hard to push through several rounds at a buffet. So I think this is a calculated move. Savy eater might stop injections a week ahead; maybe they can get a couple addition bowls down.
If the pool to pull from is this Sub, we gonna need alot of GLP1
Homie is simultaneously an inch and a mile from closing the cognitive gap that the existence of a cure doesnβt make the thing that caused the illness good for you. His entire premise is something tantamount to βI can have all the transfats I want because GLP-1s existβ.
All they do is dilute like thereβs no tomorrow. This drug pipeline was looking really good until the GLPβs came online and now those look like theyβre primed to be the main MASH treatment drugs
Great business, I just can't make the price work. Operating margin is about 45% and ROIC close to 30%, but trailing profit includes a one-off DKK 26.8B non-cash reversal, so earnings look better than they are. In the US GLP-1 market it has about 39% against roughly 61% for Lilly, and around three quarters of sales sit on a compound whose patent runs out in 2031-32. My models land near $32 against $38.60 today. I think a lower dose helps volume more than margin, but I'd like to hear the other side.
All of that information is well known, and you guessed it, priced in. They had a blockbuster drug, but Lilly is taking over in the GLP-1 race with new drugs and indications.
They canβt afford GLP, the plebes.
It temporarily got priced as the main company to make money off GLP1βs, but it became pretty clear that wasnβt gonna be the case soon after
GLP-1 have already been out though including oral pill and KO is doing great
They accidentally discovered GLP-1 but generally suck at innovation and are no once again being outclassed
Good company but LLYβs GLP-1 turned out to be better.
Itβs on a discount, overall solid company. Pretty good dividend and cash cow. Us gov disrespecting IP, competition from Eli Lilly and the fall of popularity of GLP-1 definitely hurt the company. However eu market is still going to be there. Besides they have lots of government support in the from healthcare providing insulin. Iβm down 16% on them and couldnβt care less. Iβll buy some more and hold for a few years at least. Will observe trends and review financials periodically until they have the patent
Free GLP-1 for the kids
They were the only player Then Eli Lilly launched tirzepetide, and theyβre scheduled to launch retatrutide next year or 2028 Both of which are more effective at cutting weight. Where as novo nordisk own 2.generation GLP-1 drug failed to live up to the investor expectations (although the results were within the pharmaceutical expectations) and the stock tanked, even though they still make money, hand over fist
Not a single comment mentioning the lawsuits about their GLP making people go blind
Competition. They were the only ones to offer GLP-1 medication until they weren't.
They were bought up because everyone thought Ozempic would be a money printer. Then the market realised that they aren't the only player in the GLP1 game and their future drug pipeline has had some setbacks in clinical trials. That
Menopause? Blast some TRT and get on a GLP1
The expectation gap makes sense to me, but there's a statistical catch in that comparison. March's 88% versus 60% came from a post hoc subgroup selected for greater prior GLP-1 weight loss and longer ablation. October's 80% versus 67% is from the larger pivotal mITT analysis. Those aren't like-for-like populations, so I wouldn't read the narrower gap as proof the treatment effect literally halved. The six-month result did meet its prespecified endpoint (p=0.0023). I'd also look at the actual body-weight regain: 5.1% versus 8.2%, rather than just the retention headline. The separate 12-month co-primary endpoint is still pending, with results expected in Q1 2027. That leaves a real clinical signal alongside uncertainty about durability, authorization and commercial uptake. Financing risk can weigh on valuation, but it doesn't by itself establish what caused that day's selling. Company sources: March: [https://ir.fractyl.com/news-releases/news-release-details/fractyl-health-reports-fourth-quarter-and-full-year-2025](https://ir.fractyl.com/news-releases/news-release-details/fractyl-health-reports-fourth-quarter-and-full-year-2025) October: [https://ir.fractyl.com/news-releases/news-release-details/fractyl-healths-revita-meets-six-month-co-primary-endpoint](https://ir.fractyl.com/news-releases/news-release-details/fractyl-healths-revita-meets-six-month-co-primary-endpoint)
No sell data center to buy GLP-1
Guys, please look into GLP1s. Apparently they help with gambling addiction as well.
Don't decide the to be either a bull or a bear. Be nimble. Adjust your views. And take GLP1s. They apparently reduce gambling behaviors. YOU need to get off 0dtes.
Patents. If they are first to discover novel medicines, treatments, materials, chemicals, etc and get the patent, each one creates a 20-year moat. Just look at the patent-collapse of the major pharma companiesβthey were looking pretty cooked after the mass experies, until GLP-1s came along
Its overrated! Give the people what they want, GLP1s!!!
Victoria secret is up over 300% since GLP-1s came out 
Pure value plays like MCD are traps right now because 11% of U.S. adults currently take GLP-1 medications for weight loss. Even Pepsi is going to start to feel the pain when obesity is cured. Reminds me of alcohol sales. Americaβs Heaviest Drinkers Consume Almost 60% of All Alcohol Sold [https://www.newsweek.com/americas-heaviest-drinkers-consume-almost-60-all-alcohol-sold-1520284](https://www.newsweek.com/americas-heaviest-drinkers-consume-almost-60-all-alcohol-sold-1520284) I imagine the numbers are similar for junk food and fast food services. I am up over 50% on my LLY to capture this but don't want to add any more. Maybe I should.
You're forcing correlations. How many GLP-1s did they have back in 2000? Did McDonald's have a CEO who didn't know how to eat a hamburger then?
> GLP-1 > bearish Might want to up that dose to reach otter status.
What about the current large amount of supply in the market, along with the GLP-1 macrotrend. These two factors make me bearish, in spite of El NiΓ±o.
There are actually a lot of reasons. For example, millions of people are now taking GLP-1 drugs that didn't exist a few years ago. That money has to come from somewhere.
Everything looks so utterly weak, yet this market has Pavlovian trained me that I'm just expecting a bounce any second now for no particular reason. But I couldn't even tell you why any more. Tech is an absolute disaster. Are we riding GLP-1 and soda to AtHs? They don't even go together!
Anecdotally, paying for a GLP-1 is the best financial decision Iβve made all year. Made food inflation almost completely irrelevant for me.
All the pay outs for GLP 1s and their derivatives.
>A friend of mine is having their insurance double just so their plan will cover GLP1s This is likely not true. Insurance companies seem to be using this as a scapegoat but insurance premiums are increasing just as much on plans that do not cover GLP-1s. My experience on the employer side is that it is being marketed as "Insurance rates are increasing BUT we're going to start covering GLP-1s". Granted that is just my observation as the person who negotiates with insurance companies for our employer provided insurance plan.
*short-term* profits, no less. GLP-1 drugs reduce the risks of chronic diseases
Your insurance isn't going up because of GLP-1s, it's going up because the insurance industry values profit more than human life.
Last year our University was in the process of renegotiating the contract with Blue Cross Blue Shield, it was UUGGGLLLYYY, both the University and the company calling each other out in public, lots of mud slinging both ways. Turns out the number one driver of health insurer rate increases right now is GLP1 coverage. Prescription services are cutting coverage on dozens, if not hundreds of medications, jacking up prices everywhere they can, all because of GLP1's. There's going to be a reckoning soon, at some point you literally cannot take anymore from a population while charging them more for the limited stuff they get. When healthcare and insurance coverage is tied to employment and you basically force employers to pay extortionate prices for coverage that just ends up not covering the basics people need to survive, well, the French have had a few things to say about those situations over the last several centuries.
Which is a stupid (and should be illegal) reason from the insurance companies. Someone on GLP1s is cheaper to insure in the long run because the health issues associated with obesity. They are using this as an excuse to raise prices in the short term while they cash in on long term savings. At least the ACA has the 80/20 (or 85) rule...for now.
My company just announced weβre getting an increase that will be announced laterβ¦aka itβs gonna be a bunch. Rumor has it itβs due to the GLP1 coverages. A friend of mine is having their insurance double just so their plan will cover GLP1s
Their coffee sucks though. Starbucks is a fierce competitor with Brian Niccol now. They are both losing competition to local coffee shops with specialty coffee and for folks that are cutting back because recessions due matter, itβs instant Walmart coffee. Lastly, because of the high sugar itβs going to continue to be crushed with the boom in GLP-1. Good luck though bro thatβs balls of steal
No, you used 2000 not 2020. Cumulative CPI since 2020 is like 35% and the money supply claim is false. The M1 definition changed to include savings accounts. The actual money supply increased also around 32%. What the OP post actually shows is how AI has inflated valuations of AI/computer companies while it has not helped the valuations of energy, medical (with the exception of GLP1) and finance sectors.
I hate GLP1s. Every commercial is a GLP1 ad telling me for the 1000th time Sulfonylureas don't mix with it.
I love GLP1. I have complete control over my diet. Cant wait for them to cook up some steroids that dont make your heart explode.
Ohh I forgot. Natural GLP1 without the ring worms
I fucked up. This torta I showed no interest in a year ago got on GLP 1 and is now a smoke show holy shit what do I do :kekh: :kekh: :kekh:
With the rise of GLP1s and the general unaffordability of fast food to the lower classes who primarily make up the customer base of fast food restaurants, I canβt think of a worst investment to make right now.
Thatβs not aging son. Thatβs overuse of GLP one drugs.
they will come back to the old ways once the GLP1 treatment ends lmao
Fat chicks in my office all on dat GLP1
they don't go off the GLP1s, they start wondering why its so hard to maintain a good weight when you start killing your bodies ability to regulate its appetite to come off of it has its own host of issues that pop up. i am sure many runners use it, and it is a miracle drug for people suffering from diabetes. I just think people taking it for vain weight loss without the other side of discipline in both eating inputs and exercising outputs doesn't improve their drive to also want to run or exercise.
Just spent 75% of my paycheck on Prime Day and the other 25% on my GLP1 medication. Covfefe
βIf they canβt get you with fear, theyβll get you with greedβ β¦ so youβre saying that there are anti-vaxxers out there that are now taking GLP-1s? Β What about the people who are vaxxed and taking GLP-1s, is that a double-dose or do they cancel themselves out?
yeah that too so that guys point was way off has nothing to do with asians our white people are wayyy fitter than yours by a large margin 42% obese white americans to only 26% obese white canadians and i see this even the girls like i mentioned earlier that were obese she actually loses the weight and transforms you guys before GLP ones she did this before that btw but you guys before BODY POSITIVITY BULLSHIT LOL NO ONE BELIEVES THAT AS WE CAN SEE WITH GLP 1'S
So my mom is on oral wegovy now. I manage her meds. Somehow I think I lost about 10 tablets? That's like $50 that I have somehow lost. calls for Novo i guess, but Lilly's GLP-1s are better. she just can't afford them w/o insurance. so also calls for lilly?
The new Nike Air GLP-1
Many runners use GLP1's to hit and maintain race weight. And GLP1's do not improve your aerobic ability or improve cardiovascular health in the same way running does. As more people take GLP1's and drop weight to the point where they can run without such stress on joints, I think they will be far more likely to take up running than without the GLP1's
Nothing a little GLP-1 canβt cure
Now that GLP-1s are very accessible can we make it socially acceptable to be critical of fat people again?
that is all models, the GLP1 stare.
GLP1's just doing a number to your thesis that running shoes are popular and will sell well into the future.
I mean once the enconomy improves and more of us can afford GLP1, I think fashion will boom again. Right now everyone is too broke and only able to eat the cheap fatty foods more often. That is my theory, no real backing either
even though revenueβs ticking up, the big picture is volume wobble + margin squeeze. GLPβ1 drugs, private labels and the assetβheavy distribution model are eating at topβline stability, while the dividend has been a bit too generous for the freeβcashβflow brain. it feels more like a channels problem than a marketing one.
There are GLP-1 commercials touting average loss of 25 lbs. But the people in the commercials look 250 lbs.
I can give you prescriptions for GLP-1
October is National GLP-1 month. Get fit you fat fuks
This country is fat & it's sad despite GLP-1 drugs, smart devices/AI to guide you on your health, and more access to nutrition and fitness information than any generation in history. At some point, technology can give you every tool imaginable, but it still can't make you put down the fork and go for a walk.
I was too addicted to day trading, it was actually when I started taking GLP-1s ( supposedly they help people quit addictions as well) that I was able to shake that addiction. Now I just slow roast my investments accounts and am still on track to retire early. If you start stacking your money now youβll have enough to retire. Ignore now the fats money hype and increase your income if you want to feel βwealthyβ
Google trends shows almost every from of exercise is trending up in the US in the recent years. GLP-1s + Smart watches + Strava are creating an exercise renaissance. Even if Nike is losing its edge in the sports industry, it's not going to go bankrupt in this environment.
First propagate the body positivity movement (it's okay to be fat!), and then release GLP-1 medications on the market while making initial fatfluencers promote it. You could not make it up peeps!
GLP-1s reported to decrease gambling addiction. Long term puts on WSB
Itβs literally been studied before GLP1s started to become available for obesity that skinnier people are less hungry than obese people - in other words their hunger hormones behave differently. The obsession with pretending everyone is identical and self-control is the only thing that matters is as bad as the obsession with pretending that being 200lb overweight is healthy. Not to mention insulin sensitivity, thyroid issues and other metabolic issues that people face either because of their own choices, accidents or just the genetic lottery. And societal factors too. My dad is on a GLP1 for diabetes and is obese and he basically hasnβt lost weight because he has no self control and loves calorie dense food. Again, if obesity existed because of self control, GLP1s wouldnβt be helping bring down the obesity rate. For most people, it brings their hunger hormones and the signals firing throughout their body that would normally tell them they need to eat all the time to a similar level to what most people who are skinny without much effort feel as their baseline. Which is also why often when people come off, they gain the weight back. Itβs well studied that the reason people gain weight back is because itβs almost impossible for people to have that much self control for that long. It might be fun for some skinny people to delude themselves into thinking theyβre *just that strong of a person* but itβs truly just delusion.